Your browser doesn't support javascript.
loading
Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia.
Sun, Xiaohong; Liu, Wei; Luo, Binyu; Ma, Dongwei; Kalluru, Hindu; Zhou, Yangmei; Li, Jin; Peng, Ao; Liu, Yuwang; Tong, Xin; Sun, Lei; Teeter, John; Raje, Sangeeta; Yang, Renchi.
Afiliação
  • Sun X; Development China, Pfizer Investment Co. Ltd., Beijing, China.
  • Liu W; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Luo B; Pfizer (China) R&D Center, Shanghai, China.
  • Ma D; Pfizer (China) R&D Center, Shanghai, China.
  • Kalluru H; Pfizer Healthcare India Private Ltd., Chennai, India.
  • Zhou Y; Pfizer (China) R&D Center, Shanghai, China.
  • Li J; Pfizer (China) R&D Center, Shanghai, China.
  • Peng A; Development China, Pfizer Investment Co. Ltd., Beijing, China.
  • Liu Y; Development China, Pfizer Investment Co. Ltd., Beijing, China.
  • Tong X; Pfizer (China) R&D Center, Shanghai, China.
  • Sun L; Pfizer (China) R&D Center, Shanghai, China.
  • Teeter J; Pfizer Inc, Groton, Connecticut, USA.
  • Raje S; Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Yang R; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Haemophilia ; 29(4): 1155-1159, 2023 07.
Article em En | MEDLINE | ID: mdl-37339017
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemofilia A Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemofilia A Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article